FT.MDR.74: intra-articular hyaluronic acid device officially registered in Iraq We are pleased to announce that the FT.MDR.74 medical device has been officially registered with the Ministry of Health of the Republic of Iraq, confirming full compliance with international regulatory standards and its high profile of quality and safety. FT.MDR.74 is a Class III medical device…
A Detailed Analysis of the Combined Effects on Resistance Training in Male Volleyball Players The goal of increasing sports performance and optimizing physiological adaptation is a constant driver of research in the scientific world. In this context, attention has focused on the effectiveness of natural supplements in improving muscular endurance and explosive power. Two compounds…
Gruppo FarmaImpresa at the Top of European Quality: Maximum Safety for Gynecologic Well-Being The EU Regulation 2017/745 (MDR) is Europe’s most stringent framework for manufacturing and marketing medical devices. It raises the bar on safety, quality, and traceability, introducing far stricter requirements than previous directives. For Gruppo FarmaImpresa, obtaining MDR certification for the Class IIb…
Radiation-Induced Oral Mucositis: A Debilitating Side Effect for Nasopharyngeal Carcinoma Patients Nasopharyngeal Carcinoma (NPC), particularly prevalent in Southern China and more common in men aged 40 to 59, is primarily treated with radiotherapy due to its high radiosensitivity. However, this life-saving treatment often triggers significant toxic side effects, including Radiation-Induced Oral Mucositis (RIOM). RIOM, which…
FT.CE.18 ear spray for ear canal hygiene, protection and prevention The registration of the FT.CE.18 medical device with the Executive Department of Medical Devices Evaluation of the Medical Devices Sector of the Kingdom of Saudi Arabia marks a significant milestone in the international expansion of medical devices designed for ear hygiene and protection. This approval…
Discover our innovative technologies for the future of formulation We are excited to announce that we will once again be present at CPHI Worldwide in Frankfurt, the most important global event for the pharmaceutical and nutraceutical industry. We look forward to seeing you from October 28 to 30 2025, Hall 5 Booth 50A84, to present…
Lattawin Ovules: the effective medical device against irritation and intimate burning Dryness, burning, itching, irritation, and discomfort during intercourse are common but often overlooked symptoms that affect many women at all stages of life. Whether due to hormonal changes, menopause, stress, antibiotic use, or imbalances in the vaginal microbiota, these disturbances can compromise quality of…
Introduction to Alzheimer’s disease and current therapies Alzheimer’s disease (AD) is the most common form of neurodegenerative dementia and represents a growing health challenge. In 2022, about 55 million people were affected, and it is estimated that the number could reach 139 million by 2050. Current treatments are only symptomatic and show limited efficacy: they…
Acne: problems and the search for new solutions Acne vulgaris, a dermatological disorder that mainly affects adolescents and young adults, goes far beyond simple aesthetic problems. Its physical manifestations, such as comedones, papules, and pustules, can leave permanent scars, while the psychological impact, which includes anxiety and depression, compromises the quality of life. While numerous…
Clinically Proven Effectiveness of Our Hyaluronic Acid-Based Vaginal Medical Device for Women’s Intimate Health Gruppo FarmaImpresa is proud to share the results of its clinical study, conducted on the medical device Revaginal Ovules. The study evaluated the safety and effectiveness of our vaginal ovules in promoting vaginal and uterine tissue regeneration, offering an innovative and…